Trial Profile
An Open-Label Study Assessing the Safety and Efficacy of Naltrexone Sustained Release (SR) in Combination With Bupropion Sustained Release (SR) in Overweight and Obese, Nicotine-Dependent Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2014
Price :
$35
*
At a glance
- Drugs Naltrexone/bupropion (Primary)
- Indications Drug dependence
- Focus Therapeutic Use
- Sponsors Orexigen Therapeutics [CEASED]
- 24 Dec 2014 New trial record